It is generally thought that development involves both a progressive restriction in the range of possible fates, as well as a gradual expression of molecules specific for particular differentiation pathways or lineages. There are, however, very few cases in the vertebrate nervous system in which a lineage has been studied in sufficient detail so that successive stages of differentiation and commitment can be delineated. A significant
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'Present address: Amgen, Inc., Amgen Center, Thousand Oaks, CA 91320-1789. Copyright© 1991 Society for Neuroscience 0270-6474/91/113493-14$05.00/0 technical limitation in this effort is the lack of markers specific for the various stages of development within a particular lineage. Without such markers, cells making key phenotypic decisions cannot be identified. It has been especially difficult to find molecular labels for committed progenitor cells. Monoclonal antibodies can be used as highly specific markers, and the hybridoma method can be manipulated so as to enhance the likelihood of obtaining antibodies against rare antigens of interest (Matthew and Patterson, 1983; Barald and Wessels, 1984; Agius and Richman, 1986; Barclay and Smith, 1986; Golumbeski and Dimond, 1986; Hockfield, 1987; Mahana et al., 1987; Matthew and Sandrock, 1987; Norton and Benjamini, 1987; Huse et al., 1989; Chaudhary et al., 1990) . We have used the cyclophosphamide immunosuppression method (Matthew and Patterson, 1983; Matthew and Sandrock, 1987; Ou et al., 1991) to produce a number of antibodies that shed new light on the early stages of the sympathoadrenal (SA) lineage.
The cells of the SA lineage are derived from the neural crest, and they include the neurons and small intensely fluorescent (SIF) cells of sympathetic ganglia, and the chromaffin cells of the adrenal medulla and the extraadrenal chromaffin bodies (Le Douarin, 1982) . While these cells all produce catecholamines that are secreted in response to electrical stimulation, they can be distinguished by morphological criteria, including the size of the cell body, the presence or absence of neuronal processes, the size of transmitter-storing vesicles, and the intensity of their catecholamine histofluorescence (cf. Doupe et al., 1985a,b) . Molecular differences include the level of tyrosine hydroxylase (TH) and the presence of neuron-specific markers such as SCG 10 and neurofilament (NF) (Anderson and Axel, 1986) . The epinephrine synthesizing enzyme, phenylethanolamine N-methyl transferase (PNMT), can also be used as a marker for chromaffin cells, but not all chromaffin cells express the enzyme (Bohn et al., 1981; Coupland and Tomlinson, 1989) .
While each of the three major cell types in this lineage expresses a stable differentiated phenotype in the adult organism, the cells can be interconverted. Studies of single cells in culture have demonstrated that chromaffin cells from neonatal or adult rat adrenal glands can be made to extend processes and transform into normal sympathetic neurons (Unsicker et al., 1978 (Unsicker et al., , 1985 Doupe et al., 1985a; Unsicker and Lietzke, 1987; Seidl and Unsicker, 1989) . Similarly, individual SIF cells can be converted into chromaffin cells or neurons (Doupe et al., 1985b) . SIP and chromaffin cell survival and differentiation are promoted by glucocorticoid Soinila and Eranko, 1984 ; Doupe et al., l 985a,b), while neuronal differentiation is enhanced by NGF (Unsicker et al., 1978; Doupe et al., 1985a) and basic fibroblast growth factor (bFGF) (Claude et al., 1988; Stemple et al., 1988) . Similar interconversions may occur in vivo following manipulation of these factors; glucocorticoid injections in neonatal rats increase the number of SIF cells in sympathetic ganglia (Eriinko and Eriinko, 1972; Piiiviirinta and Eriinko, 1982; Piiiviirinta et al., 1984) , NGF injections result in the replacement of adrenal chromaffin cells by sympathetic neurons (Aloe and Levi-Montalcini, 1979) , and injections of anti-NGF antibodies diminish neuronal number while enhancing the number of SIF cells (J. F. Carnahan and P. H. Patterson, unpublished observations).
These in vitro and in vivo observations suggest that the various SA cell types are derived from a common progenitor, rather than each following an independent line of differentiation from the neural crest (Landis and Patterson, 1981; Anderson, 1989; Unsicker et al., 1989) . In fact, bipotential cells that can give rise to chromaffin cells or neurons in culture have been derived from neonatal rat sympathetic ganglia (Jacobowitz and Greene, 1974; Doupe et al., 1985b) and embryonic adrenal medullae (Anderson and Axel, 1986; Seidl and Unsicker, 1989) . In addition, cell lines were produced from embryonic adrenal medulla that respond to bFGF by the expression of neuronal markers, and this differentiation can be delayed by growth in glucocorticoid (Birren and Anderson, 1990) . In an effort to identify SA progenitor cells in situ and to develop tools for isolating them from embryonic ganglia, we sought to produce monoclonal antibodies that selectively bind to the progenitors. Our approach was based on observations that suggested that the putative progenitor cells share properties in common with chromaffin and SIF cells. For example, the cells of the early embryonic ganglia express high levels of TH and catecholamine histofluorescence as do chromaffin and SIF cells (Eriinko and Eriinko, 1977; Mascorro and Yates, 1980; Taxi et al., 1983; Soinila, 1984; Soinila and Eriinko, 1984) , and the latter cells can give rise to neurons in culture, as discussed above. Therefore, certain antibodies that bind to antigens expressed in chromaffin cells but not in sympathetic neurons might also bind embryonic SA progenitor cells. We injected mice with adult rat sympathetic ganglia and suppressed the response with cyclophosphamide, and then injected the mice with neonatal rat adrenal medullae. In this way, the mice were tolerized to antigens shared between neurons and chromaffin cells. We describe the properties of five monoclonal antibodies (SAI-5) that bind adult rat chromaffin cells but not sympathetic neurons.
Some of this work has appeared previously in preliminary form (Carnahan and Patterson, 1988) .
Materials and. Methods

Production of monoclonal antibodies
Antigen preparation. Adrenal medullae of neonatal (l-3 d) SpragueDawley rats (Simonsen Laboratories, Gilroy, CA) were rapidly separated from the adrenal cortex by dissection on ice, in L-15-air medium (Hawrot and Patterson, 1979) . Both cortex and medullae were saved. Adult rat superior cervical ganglia (SCG) were dissected, and cleaned in L-15-air medium on ice. If not processed immediately, the tissues were frozen at -20°C. Tissues were homogenized using a clean glass homogenizer in phosphate-buffered saline (PBS) (M. A. Bioproducts, Walkersville, MD) containing 5 mM phenylmethylsulfonyl fluoride (PMSF; Sigma, St. Louis, MO) and 25 mM ethylenediaminetetraacetic acid (EDTA; Sigma), pH 7.4, on ice. Homogenates were centrifuged in an Airfuge at 30 psi for 30 min. Pellets were resuspended, sonicated lightly on ice, and assayed for protein using the Bradford assay (BioRad, Richmond, CA; bulletin l 069), using bovine serum albumin (BSA) as the standard.
Hybridoma production. RBF!m (Taggart and Samloff, 1983) and Balb/c mice were injected with antigens according to the schedule described below. The myeloma cells used for the fusions were HL-1 (Taggart and Samloff, 1983) Kohler and Milstein (1975) . Cells were plated at a density of 2 x 10 6 /ml, with 150 µI/well (i.e., 3 x 10 5 cells/well).
Secretion assay
Antibody secretion was assayed by applying I µl of each hybridoma supernatant to a nitrocellulose membrane (Schleicher & Schuell Inc., Keene, NH) (Hawkes et al., 1982) . After drying at room temperature (RT) for 1 hr, membranes were blocked by incubation in PBS containing 10% normal goat serum (NGS) for 1 hr with gentle shaking and then incubated for 1 hr at RT with goat anti-mouse IgG conjugated to peroxidase (Chemicon International Inc.), diluted 1: 100 in PBS containing 2% NGS. Membranes were washed three times with PBS plus 2% NGS, 5 min each, and three times with PBS. The peroxidase reaction was revealed by incubating the membranes in a solution of 5 vol of PBS plus 1 vol of 3 mg/ml 4-chloronaphtol (Merck) iq methanol and activated with 0.0 I% H 2 0 2 •
I mmunohistochemistry
Freshly dissected tissues were rapidly frozen in O.C.T. Tissue Tek (Milles) on dry ice. Sections (7-10 µm) were cut on a cryostat (Hacker Instruments Inc.), collected on multispot microscopic slides (C. A. Hendley, Essex, England), and air dried. Sections were either used immediately or stored at -30°C for 2-3 weeks. Embryonic tissue, however, was never kept frozen for longer than a few days, even after fixation. If the specimen had been fixed, the slides were gelatin coated to increase their adhesivity.
Immunostaining of fresh-frozen sections involved a first step of blocking nonspecific binding of the primary antibody for 30 min at RT with PBS containing 10% NGS. Sections were then incubated for 1 hr at RT, or overnight at 4"C, with monoclonal antibody or a rabbit antiserum. Sections were washed by three incubations of 5 min each of PBS plus 2% NGS and then blocked again using PBS plus l 0% NGS, 30-60 min at RT. Secondary antibody (high-fluorescein-<:onjugated, goat anti-mouse lgG; Antibodies, Inc.) or biotinylated horse anti-mouse IgG (Vector Laboratories) was incubated on the sections with an equal volume of rat serum (to decrease nonspecific binding) for 30 min, on ice. Before use, secondary antibodies were diluted (usually l: 100 in PBS plus 2% NGS) and centrifuged in an Eppendorf centrifuge for 5-10 min.
For double staining, a high-fluorescein anti-mouse antibody was used to detect monoclonal antibodies, and a biotinylated goat anti-rabbit antibody (Vector Laboratories) was used to detect rabbit polyclonal antibodies; these were incubated on sections simultaneously for l hr at RT. After washing as described above, sections were rinsed three additional times with PBS to remove all serum (known to contain biotin). Staining was concluded by incubating sections for 15-30 min at RT with streptavidin-Texas red (Amersham), diluted 1: 100 in PBS. Double staining with two monoclonal antibodies (HNK-1, an IgM, and SAi, an lgG 1) was used prior to the availability ofbiotinylated SA2. Isotypespecific secondary antibodies [rhodamine-conjugated goat anti-mouse lgM (T AGO) and fluorescein isothiocyanate (FITC) goat anti-mouse IgG (Southern Biotech, Inc., Atlanta)] were used to distinguish the monoclonal antibodies. Sections were briefly rinsed and mounted using glycerol containing a 10% solution of PBS, pH 8.0, and 10 mg/ml phenylenediamine (Johnson and de Nogueira Araujo, 1981) to reduce fading of fluorescence. Sections were examined on an inverted Zeiss microscope with epiillumination fluorescence using an FITC filter set (excitation 450-490 nM, emission 515-565 nM), a Texas red filter set (excitation 530-585 nM, emission 615 nM), or a rhodamine filter set (excitation 510-560 nM, emission 590 nM). Two independent fusions, using RBF/m and Balb/c mice, were carried out as described in Materials and Methods. Hybridoma supernatants were initially assayed for the presence of antibody using a dot blot method. The first two data columns denote the percentage of hybridoma-containing wells that contained antibodies (%) and the corresponding absolute number of secreting hybridomas (Total). Antibodies were screened for their binding to unfixed, frozen sections of adult and neonatal SCG and neonatal adrenal medullae (AM). The histochemical results are expressed as percentages of the total number of antibodies screened for that fusion.
Staining for TH, PNMT, and NF involved fixing animals; adult rats were anesthetized with ether and perfused through the heart using a 23 gauge needle with PBS, followed by 4% paraformaldehyde in 0.1 M PBS, pH 7.4. For embryonic tissue, the animal was divided into three or four segments and fixed in 4% paraformaldehyde in PBS for several hours at 4°C. The pieces were then immersed in 20% sucrose in PBS until they sank to the bottom of the container, whereupon they were frozen and sectioned. The rabbit anti-TH antiserum (Eugene International, Inc.) was diluted l: 100. Neurofilament staining was visualized using a 1: 100 diluted rabbit antiserum to melanocyte stimulating hormone (anti-MSH; Immunonuclear Corp.), which was shown to detect the 140 kDa NF subunit (Drager et al., 1983) . Anti-PNMT rabbit antiserum was a gift from Dr. M. Bohn (National Science Foundation). Anti-PNMT staining involved incubation in 10 mM PBS, pH 7.6, containing 0.5 mM NaCl; blocking steps were in this buffer, containing 10% horse serum, 3% NGS, and 0.3% Nonidet P-40.
Fixation of cultured cells involved rinsing the dishes with PBS and exposure to 4% paraformaldehyde for 10 min, on ice. Fresh fixative solution at pH 7.4 was used, and 0.1%Tween20 was routinely included to permeabilize the cells. The staining protocol was as for tissue sections.
Biotinylation of antibodies
Ascites fluids were generated according to Galfre and Milstein (1981 ) , and antibodies were partially purified by ammonium sulfate precipitation. After resuspension and dialysis against PBS, pH 8.0, containing 30 mM NaCl, antibodies were further purified on a DE-52 column (Whatman) (Hudson and Hay, 1980) and concentrated using a Centricon 30 device (Amicon). Prior to biotinylation, antibodies were dialyzed against 0.1 M borate buffer, pH 8.5, and the protein concentration was adjusted to 2 mg/ml using the Centricon 30. An aliquot of this solution (100 µg; 50 µl) was added to 20 µl ofbiotinamidocaproate N-hydroxysuccimide ester (30 µM in dimethyl sulfoxide; Sigma) and incubated for 1 hr at RT. To stop the reaction, 5 µl of 2 M glycine was added for 5 min. The antibody solution was diluted with PBS and centrifuged three times in a Centricon 30 to remove unbound biotin. Labeled antibodies were frozen in aliquots until use. Histological staining of fresh-frozen sections of neonatal adrenal glands revealed that the SA2 antibody maintained its original titer of binding to sections after biotinylation.
Competition experiment
The staining of biotinylated antibody SA2 was assessed after coincubation with each unlabeled sympathoadrenal (SA) antibody on sections of unfixed, neonatal rat adrenal medulla. The concentration of labeled SA2 was chosen so that a clear diminution of staining was observed when it was diluted twofold with PBS. The concentration of each unlabeled antibody was >IO-fold higher than that required for optimal staining using indirect immunofiuorescence. Incubation with unlabeled SA2 abolished the staining by labeled SA2.
Primary culture of chromaffin cells
Cell preparation. Neonatal rat adrenal medullae were dissected free of cortex in L-15-air. Chromaffin cells were dissociated using a modification of the method of Unsicker et al. (1978) . After a brief wash in calcium/magnesium-free Hanks' balanced salt solution (HBSS; GIB-CO), medullae were incubated at 37°C for 40 min in 1 mg/ml collagenase (Worthington Biochemical Corp., Freehold, NJ) and 5 mg/ml dispase (Sigma) in the same HBSS. The resulting cell suspension was centrifuged at 100 x g twice, resuspended in growth medium, and plated at 500-1000 cells per well.
Culture dishes and substrata. The 5 mm wells were made by attaching Aclar (Allied Chemical Corp., Morristown, NJ) coverslips to Petri dishes with paraffin according to Hawrot and Patterson ( 1979) . The dishes were sterilized by UV irradiation and coated with 50 µl of a Matrigel solution (Collaborative Research) as described by Stemple et al. (1988) . Alternatively, wells were coated with rat tail collagen (Hawrot and Patterson, 1979) . Similar results were obtained with both surfaces, but neurite outgrowth was faster on the Matrigel-coated coverslips.
Culture media. Cells were plated in L-15-air and grown in L-15-CO, growth medium as described by Doupe et al. (1985a) . The growth medium was supplemented with 5% rat serum. Other additives included 1 µM dexamethasone phosphate (Merck, Sharp & Dohme) and 1 µg/ml 7S NGF (Mains and Patterson, 1973) .
Results
Generation of cell-specific antibodies by immunosuppression
Two independent fusions were carried out, using RBF/m mice for one and Balb/c mice for the other. The RBF/m strain is used to enhance the frequency of antibody-secreting hybridomas (Taggart and Samloff, 1983) . Our results with dot blots confirmed the increased efficiency of RBF/m-derived hybridomas (80% of the wells contained secreting antibodies, for a total of 275 antibody-secreting hybridomas; Table 1 ) as compared to the commonly used Balb/c strain (19% and 10; Table 1 ). Although this particular Balb/c fusion yielded an unusually low number ofhybridomas and percentage ofsecretors, RBF/m mice routinely yield higher numbers in our hands.
All antibody+ supematants were screened for binding to unfixed, frozen sections ofadult and neonatal rat SCG and neonatal rat adrenal medullae, using standard immunohistochemical methods. The distribution of binding in these tissues was quite similar in both fusions (Table 1 ). The results demonstrate the effectiveness of the cyclophosphamide method, in that many more antibodies bound to the nonsuppressed antigen (adrenal medulla, 43) than to the suppressed antigen (sympathetic ganglion, 18). Many other fusions, using the same procedures but without suppression, have demonstrated that there is no difficulty in generating antibodies against SCG membranes (J. Imrich and P. H. Patterson, unpublished observations).
SAJ-5 binding to chromaffin cells versus sympathetic neurons
Seven clones were selected from the RBF/m fusion for further analysis. Five of these (SA 1-5) displayed bright staining of cells in the adult adrenal medulla and little or no staining of adult sympathetic ganglia. The other two adrenal medulla-selective antibodies appeared to bind extracellular material; no further experiments were carried out with these antibodies. The differ- ential staining with SA 1-5 is illustrated in Figures l and 2 . Double staining with SA 1 and PNMT confirmed the staining of chromaffin cells in the adrenal medulla (Fig. l ) . About 80% of rat adrenal chromaffin cells express PNMT (Unsicker et al., l 978a; Bohn et al., 1981; Verhofstad et al., 1985; Coupland and Tomlinson, 1989) , and SAI-5 bind the PNMT-cells as well as the clusters of PNMP cells (Fig. IA,B, arrows) . Since no SA binding is observed in areas of the adrenal that are clearly cortex, and since all SA+ cells also express TH (Figs. 4, 5) , the PNMTcells stained by the SA antibodies are very likely norepinephrine-containing adrenal chromaffin cells. Double staining of adult sympathetic ganglia with SA 1-5 and TH revealed that not only were the SA antibodies negative for neurons, but they also did not appear to bind to SIF cells in these ganglia (Fig. 1 C,D) . The latter were visualized by their high TH levels. All four panels in Figure 1 were exposed and developed comparably.
Loss of SA expression in developing sympathetic ganglia
Using the HNK-1 antibody to visualize neural crest cells at embryonic day 9 (E9) and EIO (Erickson et al., 1989) , SAI-5 exhibited no detectable binding to migrating crest cells (Fig. 3) . By El 1.5, the stage when TH begins to be expressed (Cochard et al., 1979) , each of the SA antibodies appears to bind to all TH+ cells in the SCG (Fig. 4A) . Since each of the SA antibodies displayed strong cytoplasmic staining of the embryonic ganglion, the distribution of SA I serves as an example of the set. SAI-S staining of sympathetic ganglia declines rapidly with further development (Fig. 4C,E) . Double labeling of dissociated cell suspensions with TH and SA l indicates that by E 16.5, only 25-30% of the TH+ cells are SAl +(see also . Those cells in neonatal ganglia that are still SA 1 • are also the cells most strongly positive for TH staining, while the weakly TH• cells were most often SA- (Fig. 4E,F, arrows) . That is, the last cells to lose SA staining are those that express TH most strongly (see also Anderson et al., 1991) . These are most likely SIF cells (Jacobowitz, 1970; Unsicker et al., l 978a; Taxi, 1979; El-Maghraby and Lever, 1980) . Since SIF cells in adult SCG are SA- (Fig. 1 C,D) , these results indicate that SIF cells undergo postnatal maturation.
Adrenal chromaffin cells maintain SAJ-5 expression
The developmental profile of SAl-5 staining in the adrenal medulla is quite different from that in sympathetic ganglia. In the embryonic adrenal, SAI-5 staining is detectable as the precursors migrate into the anlage (Fig. 5A) , and it is maintained through adulthood (Figs. I, 5C,E) . There is a good correlation between TH and SA staining at all ages in the medulla (Fig. 5) . In the extraadrenal chromaffin body, adjacent to the adrenal (* in Fig. 5A ), TH+ cells lose SAi staining early in development, as in sympathetic ganglia.
SA expression in other areas of the nervous system
While SA binding is correlated with high TH staining, the association is not absolute. That is, TH+ cells in tissues that are not members of the SA lineage can be SAI-5-. For example, a subpopulation of neurons in the rat nodose ganglion are strongly stained for TH (Katz et al., 1983; Katz and Black, 1986; Katz and Erb, 1990 ), but at no stage are these sensory neurons SA I+ (Fig. 6A) . The TH+ nodose neurons also do not appear to express the SA! epitope in culture (D. Katz, personal communication) . Cells of the carotid body are likewise known to contain high levels of TH (Biscoe, 1971; Pearse et al., 1973; Hansen and Christie, 1981) , and these cells are also negative for SAi from El5.5 through adulthood (Fig. 6C) . Finally, a subpopulation of sensory neurons in embryonic dorsal root ganglia have been shown to express TH transiently (Jonakait et al., 1984 (Jonakait et al., , 1985 , and SA 1 + cells were not detected in these ganglia (Fig. 6£) . SA 1 staining was also not detected in embryonic or neonatal rat brain (data not shown). SAl does, however, bind to the transiently TH+ neurons of the embryonic gut .
The immunohistochemical results are summarized in Table 2.
Discrimination of the SA epitopes
Since the tissue distribution and developmental time course of all five SA antibodies are the same, it was possible that these antibodies all bind to the same epitope. There are, however, differences in the subcellular localization of the binding of some of the antibodies. For instance, when El8.5 adrenal chromaffin cells are freshly dissociated and surface stained (without fixation and permeabilization), the following percentages of cells are positive for each of the antibodies: SAi, 74%; SA2, 77%; SA3, 9%; SA4, 53%; SAS, 13%. When these cells are permeabilized, however, each of the antibodies binds to all of the TH+ cells.
Thus, while each antibody binds well to the cytoplasmic antigen(s), the antibodies display striking differences in their recognition of surface epitopes. In addition, only SA l binds well to fixed and permeabilized chromaffin cells in culture (see Fig.  8 ). Differences in the fixation sensitivity of the epitopes in tissue sections are also apparent (data not shown). Taken together, these findings suggested the possibility that SAl-5 could be binding to several different epitopes on the same antigen, or to different antigens that exhibit very similar specificities of expression.
To test further the possibility that some of the SA antibodies bind distinct epitopes, we performed a competition experiment, using immunohistochemistry of neonatal adrenal gland sections as the assay. The SA2 antibody was directly labeled with biotin and added to the sections at a concentration just sufficient to detect staining of adrenal sections using streptavidin-Texas red. Under the same conditions, sections were incubated with labeled SA2 plus a second, unlabeled, SA antibody (the unlabeled antibody was added at a supramaxirnal concentration for staining by itself). SA2 staining was compared with and without competing antibodies. A positive control for competition is the addition ofunlabeled SA2 antibody, which completely abolishes staining ( fig. 7 F) . Three antibodies (SA 1, -4, -5) did not di- Figure 7 . Competition between the SA antibOdies indicates at least three discrete epitopes on sections. Sections of adrenal medulla were incubated with biotin-labeled SA2 antibody alone (A, C, E) or simultaneously with an unlabeled antibody (B, D, F) . Coincubation with SAi did not diminish SA2 staining (A, B) ; the same result was obtained with SA4 and -5 and a control anti-Thy-I antibody (data not shown). Coincubation with SA3 resulted in a partial inhibition ofSA2 staining (C. D). Coincubation of unlabeled SA2 with the labeled SA2 abolished staining (E. F). These results imply the existence of at least three distinct epitopes: SA2; SA 1,4,5; and SA3. Scale bar, 40 µm. minish SA2 staining (Fig. 7 B) , while SA3 showed partial inhibition of SA2 binding (Fig. 7 D) . Addition of an anti-Thy-I antibody as a negative control also did not inhibit SA2 staining (data not shown).
NO COMPETITION PARTIAL COMPETITION COMPLETE COMPETITION
Since all five SA antibodies stain adrenal sections equally brightly at the concentrations used in the competition experiment, the lack of inhibition by some antibodies implies that there are at least three different epitopes recognized by the SA antibodies; one recognized by SA2, one by the partial inhibitor SA3, and the site(s) recognized by SAi , -4, and -5. Further evidence for multiple epitopes is the finding that a mixture of at least three different SA antibodies was necessary to visualize cell surface staining in early (El4.5) sympathetic ganglia (Carnahan and Patterson, I 99 l ) . That is, addition of single antibodies at saturating concentrations did not yield detectable staining, but the staining of several antibodies simultaneously is additive. Such additivity would not be expected if all antibodies bound to the same epitope. Finally, as mentioned above, only one of the antibodies, SA 1, stains cultured adrenal chromaffin cells (Fig.Sand data not shown) , suggesting that the SAi epitope is different from those of SA2-5. Thus, the three antibodies that could not be distinguished from one another in the competition experiment can be divided into two groups, SAl and SA4 and -5. Thus, there appear to be at least four different epitopes recognized by this set of antibodies, all with the same cellular specificity.
Attempts to identify the SA antigen(s) by Western blotting and immunoprecipitation methods have thus far proved negative.
Regulation of SAJ antigen expression
As mentioned above, SA 1 stains the cytoplasm and cell surface of adrenal chromaffin cells in culture. Taking advantage of this property, we examined the influence of glucocorticoid and NGF on the expression of the SA 1 antigen. Glucocorticoid is required for the survival of rat adrenal chromaffin cells and for the maintenance of their differentiated characteristics (Doupe et al., 1985a) . This hormonal condition mimics the environment of the adrenal medulla. In the presence of the synthetic glucocorticoid dexamethasone, SA 1 staining is maintained on the chromaffin cells indefinitely (Fig. SA) . On the other hand, when glucocorticoid is removed and NGF added to the cells, they undergo a conversion to the neuronal phenotype (Fig. SF) (Unsicker et al., 1978; Doupe et al., l 9S5a; Unsicker and Lietzke, 1987) . NGF diminishes the staining of these cells by SAl, beginning as soon as 24 hr of incubation (Fig. SB) . Upon removal of dexamethasone and in absence of added NGF, cells were still SA 1 +, but its expression was weaker compared to cultures grown in dexamethasone (data not shown).
Discussion
Our goal in this project was to generate monoclonal antibodies against the surfaces of the progenitor cells of the SA lineage. Such antibodies could potentially be used to isolate the precursors by cell sorting, as well as to follow the development of these cells in vivo. Since we did not have a method for isolating significant numbers of these cells to use as an enriched source of antigen, we took advantage of the known similarities between adrenal chromaffin cells, SIF cells, and the presumed SA precursors (Landis and Patterson, 1981; Doupe et al., l 9S5a,b; Anderson and Axel, 1986) . Thus, we used neonatal rat adrenal medullae as the source of antigen and employed the cyclophosphamide immunosuppression method to lessen greatly the frequency of generating antibodies against antigens shared between chromaffin cells and other cell types. This technique essentially tolerizes the mice against common antigens and enhances the frequency of obtaining antibodies against rare or nonimmunogenic antigens (Matthew and Patterson, 1983; Matthew and Sandrock, 19S7; Suzue et al., 1990; Ou et al., 1991) . The results presented in Table 1 confirm the utility of this approach, as a significant number of antibodies were generated with the desired specificity.
Studies on phenotypic decision making within a given lineage require markers selective for each stage where new derivatives are generated. When multipotential neural crest cells differentiate into committed SA progenitor cells, TH is a very useful label because it designates cells that have taken the earliest known differentiated step in this pathway. TH and catecholamine histofiuorescence are expressed while the early SA cells are still dividing (Cohen, 1972; Rothman et al., 1978; Rohrer and Thoenen, 1987; Ernsberger et al., 1989) . In addition, TH and catecholamine production are ubiquitous markers for all members of the SA group, until transmitter choice is reversed in certain neurons postnatally (Landis and Patterson, l 9S l; Landis and Keefe, 1983) . TH and catecholamines are not, however, restricted to the SA branch of the neural crest lineage. Catecholamines and/ or their biosynthetic enzymes are found in early neurons in the gut (Cochard et al., l 97S; Teitelman et al., 1981; Jonakait et al., l 9S5; Baetge and Gershon, 1989) , in certain parasympathetic (Borklund et al., l 9S5; Iacovitti et al., 1985; Landis et al., 19S7; Uemura et al., 19S7; Leblanc and Landis, 1989) and sensory neurons (Katz et al., l 9S3; Jonakait et al., l 9S4; Katz and Black, 19S6; Katz and Erb, 1990) , as well as in the CNS. There are many other examples of such markers that are quite useful under normal conditions, particularly in situ, but that cannot be used as absolute markers of a developmental stage or subpopulation of cells. Other examples include the neuropeptides; substance P can be used to identify certain sensory neurons, but other cells can express it in vivo (Bohn et al., l 9S4) and in vitro (Kessler, 1984; Nawa and Sah, 1990 ).
The SA antibodies label the early SA cells defined by TH and catecholamine histofiuorescence, but SA expression becomes much more restricted in its distribution than the latter markers. Moreover, unlike TH, SA 1 was not detected in the CNS, nor in the sensory or parasympathetic ganglia that have been studied thus far. SA expression is also different from TH and catecholamines in that it is not found in all members of the SA pathway but rather is maintained primarily in adrenal chromaffin cells. Previous chromaffin cell markers included the very large size of chromaffin vesicles as visualized by electron microscopy (ElMaghraby and Lever, 1980) , and the enzyme PNMT, present in a subpopulation of chromaffin cells.
The SA antibodies can also be used to detect the embryonic progenitor cells that give rise to the SA lineage. This is suggested by the observations that (1) SAl labels the same cells in the early ganglion primordium as does TH (another, independent, SA lineage marker), (2) ganglionic cells isolated by virtue of their SA 1-5 antigen expression can give rise to either chromaffin cells or neurons in culture , and (3) SA+ cells initially coexpress neuron-specific markers in embryonic sympathetic ganglia, implying the existence of transiently dual-phenotype progenitor cells in vivo . In these respects, the SA antibodies are reminiscent of the antibodies that bind to certain cholinergic, parasympathetic neurons and were used to select a subpopulation of neural crest cells that give rise to these neurons (Barald, 1988) . What is the function of the antigen(s) that the SA antibodies recognize? Since the epitopes are restricted to cells producing catecholamines, they could play a role in the synthesis, storage, breakdown, or release of these transmitters. The epitopes are unlikely, however, to be part of a previously studied component of these systems because they are not detected in sympathetic neurons or in other noradrenergic neurons. The SA antigen(s) is also unlikely to be PNMT because ( l) SA l is expressed in PNMT~ chromaffin cells, (2) PNMT is cytoplasmic while SAI becomes a surface antigen, and (3) PNMT appears much later in development than does the SA antigen(s) (Bohn, 1986) . The SA antigen(s) is found in both the cytoplasm and on the cell surface, although it appears first in development in the former site and only later accumulates on the cell surface . This subcellular distribution is not that expected for synaptic vesicle membrane components; these appear on the cell surface only transiently, during periods ofintense stimulation and transmitter release (Winkler et al., 1986) . In addition, the observation that cell surface labeling at early times requires the addition of three SA antibodies simultaneously, while requiring only one antibody later , suggests that the antigen(s) is being added to the surface membrane slowly, over time.
